StemSight develops off-the-shelf regenerative cell therapies for corneal blindness. Our expertise is in the combination of iPS-derived cells with functional biomaterials - for FASTER tissue regeneration, SAFER cell therapies and EASIER cell delivery.
| Website | http://www.stemsight.fi |
| Employees | 19 (9 on RocketReach) |
| Founded | 2021 |
| Phone | +358 50 4212233 |
| Industry | Biotechnology Research |
| Keywords | Cell Therapy, Regenerative Medicine, Stem Cell Therapy, Cell Based Therapy, Cellular Therapies, Tissue Regeneration, Off The Shelf Therapy, Biomaterials, Eye Disease Treatment, Blindness Treatment, Ophthalmic Therapeutics, Induced Pluripotent Stem Cells, Biomedical Engineering, Ophthalmology, Drug Delivery |
| Competitors | Thermo Fisher Scientific, Corning Incorporated, The National Institutes of Health, Sartorius, STEMCELL Technologies, Celerion, Greiner Bio-One International, Cellomics , Inc. +36 more (view full list) |
Looking for a particular Stemsight Oy employee's phone or email?
Laura Koivusalo is the CEO and Founder of Stemsight Oy.
9 people are employed at Stemsight Oy.